Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival.
JCI Insight
; 3(13)2018 07 12.
Article
in En
| MEDLINE
| ID: mdl-29997286
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
B7-H1 Antigen
/
Programmed Cell Death 1 Receptor
/
Lung Neoplasms
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
JCI Insight
Year:
2018
Type:
Article